The data presented covered everything from its mainstay acalabrutinib, sold as Calquence, to the eye-catching AZD0120, an ...

The Department of Health (DOH) said on Saturday it is studying reforms to protect patients from exorbitant professional fees ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

“For many years, the standard of care for ASHL was based on the RATHL trial, where newly diagnosed patients were given two cycles of ABVD [doxorubicin, bleomycin, vinblastine, and dacarbazine] and ...

In the run-up to Pre-Filled Syringes West Coast in June, SMi Group caught up with Douglas Cusato from Sumitomo Rubber to discuss his presentation, current challenges and the upcoming event. A: “The ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

Discover the latest breakthroughs in multiple myeloma treatment, including CAR T-cell therapies and promising new options for ...

The FDA approved epcoritamab plus R 2 on November 18 for the treatment of patients with relapsed or refractory FL. It also granted traditional approval for the treatment of relapsed or refractory FL ...

The latest data released at ASH 2025 offer new combination therapies for the treatment of multiple myeloma and new insights into the disease.

Toronto, Ontario–(Newsfile Corp. – December 18, 2025) – CEO.CA (“CEO.CA”), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior ...